Palvella Therapeutics Inc.

PVLA | NASDAQ

Price Alert Chart Builder DCF Calculator

$153.41

+$2.85 (+1.89%)

At close: Sep 21, 2026, 4:00 PM ET

$154.50

+$1.09 (+0.71%)

Pre-market: Sep 22, 2026, 5:50 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $2.16B

Enterprise Value $1.95B

Beta -0.17

Average Volume 239.91K

Shares Outstanding (Diluted) 14.36M

Shares Change YoY 29.89%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US6979471090

Price Performance

Price Change 1M 10.4%

Price Change 3M 29.3%

Price Change 6M 27.4%

Price Change YTD 53.0%

Price Change 1Y 161.3%

Price Change 3Y 1028.0%

Price Change 5Y 1028.0%

1M CAGR (ann.) -2.8%

1Y CAGR (ann.) 166.2%

5Y CAGR (ann.) N/A

All-Time CAGR 242.3%

Valuation

PE Ratio -31.76

Forward PE N/A

PEG Ratio -1.07

Forward PEG -1.17

PS Ratio N/A

Forward PS 78.90

PB Ratio 10.15

P/FCF Ratio -46.44

P/Adj. FCF Ratio -35.37

P/OCF Ratio -60.40

EV/Sales N/A

EV/EBIT -32.41

EV/EBITDA -39.00

EV/FCF -41.17

Earnings Yield -3.1%

FCF Yield -2.1%

Adj. FCF Yield -2.8%

Financial Health

Net Cash $250.58M

Total Debt $535K

Cash & Short-Term Investments $250.58M

Total Assets $253.51M

Current Ratio 21.18

Quick Ratio 21.18

Debt / Equity Ratio 0.00

Debt / EBITDA -0.01

Debt / FCF -0.01

OCF / Debt -88.56

Interest Coverage -7.60

Altman Z-Score 34.82

Piotroski F-Score 4

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -31.3%

Returns

Return on Assets -24.3%

Return on Equity -47.8%

Return on Invested Capital -23.9%

Return on Capital Employed -23.9%

Return on Tangible Assets -24.3%

Historical Growth (CAGR)

Revenue CAGR 3Y -150.0%

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 64.3%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y -34.2%

FCF CAGR 5Y -19.7%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 11

EPS Growth Next 3Y 46.7%

Revenue Growth Next 3Y N/A

Earnings Date Nov 9, 2026

EPS Estimate (next Q) -$1.74

EPS Growth Est (next Q) 68.5%

Revenue Est (next Q) $16.67K

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $232.25

Price Target Upside 51.4%

Cash Flow

Operating Cash Flow $-47.38M

Free Cash Flow $-47.38M

Adj. Free Cash Flow $-62.21M

FCF Per Share -$2.54

OCF Per Share -$2.54

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-57.74M

EBITDA $-50M

Net Income $-61.7M

EPS (Diluted) -$4.83

Revenue / Employee N/A

Profit / Employee $-2.13M

Employees 29